A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis

FASEB Journal

Volumn 23, Issue 1, 2009, Pages 143-152

  Snider, Ashley J ^a   Kawamori, Toshihiko ^a   Bradshaw, Sarah G ^b   Orr, K Alexa ^a   Gilkeson, Gary S ^b   Hannun, Yusuf A ^a   Obeid, Lina M ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Ceramide; Cyclooxygenase 2; Inflammation; Sphingosine 1 phosphate; Tumor necrosis factor alpha

Indexed keywords

CYCLOOXYGENASE 2; DEXTRAN SULFATE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; COLITIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; INFLAMMATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; SPLENOMEGALY; WEIGHT REDUCTION;

ANIMALS; BODY WEIGHT; COLITIS; COLITIS, ULCERATIVE; COLON; CYCLOOXYGENASE 2; DEXTRAN SULFATE; ERYTHROCYTES; GENE EXPRESSION REGULATION; HUMANS; LYSOPHOSPHOLIPIDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORGAN SIZE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SPHINGOSINE; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE; MUS;

EID: 58249117646     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.08-118109     Document Type: Article

References (52)

1. Obeid, L. M., Linardic, C. M., Karolak, L. A., and Hannun, Y. A. (1993) Programmed cell death induced by ceramide. Science (New York) 259, 1769-1771
2. Venable, M. E., Lee, J. Y., Smyth, M. J., Bielawska, A., and Obeid, L. M. (1995) Role of ceramide in cellular senescence. J. Biol. Chem. 270, 30701-30708
3. Seufferlein, T., and Rozengurt, E. (1994) Sphingosine induces p125FAK and paxillin tyrosine phosphorylation, actin stress fiber formation, and focal contact assembly in Swiss 3T3 cells. J. Biol. Chem. 269, 27610-27617
4. Lee, S. C., Kuan, C. Y., Wen, Z. D., and Yang, S. D. (1998) The naturally occurring PKC inhibitor sphingosine and tumor promoter phorbol ester potentially induce tyrosine phosphorylation/activation of oncogenic proline-directed protein kinase FA/GSK-3alpha in a common signalling pathway. J. Protein Chem. 17, 15-27
5. Kimura, T., Watanabe, T., Sato, K., Kon, J., Tomura, H., Tamama, K., Kuwabara, A., Kanda, T., Kobayashi, I., Ohta, H., Ui, M., and Okajima, F. (2000) Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3. Biochem. J. 348, 71-76
6. Wang, F., Van Brocklyn, J. R., Hobson, J. P., Movafagh, S., Zukowska-Grojec, Z., Milstien, S., and Spiegel, S. (1999) Sphingosine 1-phosphate stimulates cell migration through a G(i)-coupled cell surface receptor. Potential involvement in angiogenesis. J. Biol. Chem. 274, 35343-35350
7. Singleton, P. A., Dudek, S. M., Chiang, E. T., and Garcia, J. G. (2005) Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin. FASEB J. 19, 1646-1656
8. Martino, A. (2007) Sphingosine 1-phosphate as a novel immune regulator of dendritic cells. J. Biosci. 32, 1207-1212
9. Chiba, K., Matsuyuki, H., Maeda, Y., and Sugahara, K. (2006) Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus. Cell. Mol. Immunol. 3, 11-19
10. Eigenbrod, S., Derwand, R., Jakl, V., Endres, S., and Eigler, A. (2006) Sphingosine kinase and sphingosine-1-phosphate regulate migration, endocytosis and apoptosis of dendritic cells. Immunol. Invest. 35, 149-165
11. Von Wenckstern, H., Zimmermann, K., and Kleuser, B. (2006) The role of the lysophospholipid sphingosine 1-phosphate in immune cell biology. Arch. Immunol. Ther. Exp. (Warsz.) 54, 239-251
12. Meyer zu Heringdorf, D., and Jakobs, K. H. (2007) Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism. Biochim. Biophys. Acta 1768, 923-940
13. Rosen, H., Sanna, G., and Alfonso, C. (2003) Egress: a receptor-regulated step in lymphocyte trafficking. Immunol. Rev. 195, 160-177
14. Liu, H., Toman, R. E., Goparaju, S. K., Maceyka, M., Nava, V. E., Sankala, H., Payne, S. G., Bektas, M., Ishii, I., Chun, J., Milstien, S., and Spiegel, S. (2003) Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis. J. Biol. Chem. 278, 40330-40336
15. Sarkar, S., Maceyka, M., Hait, N. C., Paugh, S. W., Sankala, H., Milstien, S., and Spiegel, S. (2005) Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells. FEBS Lett. 579, 5313-5317
16. De Palma, C., Meacci, E., Perrotta, C., Bruni, P., and Clementi, E. (2006) Endothelial nitric oxide synthase activation by tumor necrosis factor alpha through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors: a novel pathway relevant to the pathophysiology of endothelium. Arterioscler. Thromb. Vasc. Biol. 26, 99-105
17. Billich, A., Bornancin, F., Mechtcheriakova, D., Natt, F., Huesken, D., and Baumruker, T. (2005) Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: function in cell survival and IL-1beta and TNF-alpha induced production of inflammatory mediators. Cell. Signal. 17, 1203-1217
18. Pettus, B. J., Bielawski, J., Porcelli, A. M., Reames, D. L., Johnson, K. R., Morrow, J., Chalfant, C. E., Obeid, L. M., and Hannun, Y. A. (2003) The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha. FASEB J. 17, 1411-1421
19. Kawamori, T., Osta, W., Johnson, K. R., Pettus, B. J., Bielawski, J., Tanaka, T., Wargovich, M. J., Reddy, B. S., Hannun, Y. A., Obeid, L. M., and Zhou, D. (2006) Sphingosine kinase 1 is up-regulated in colon carcinogenesis. FASEB J. 20, 386-388
20. Breese, E. J., Michie, C. A., Nicholls, S. W., Murch, S. H., Williams, C. B., Domizio, P., Walker-Smith, J. A., and MacDonald, T. T. (1994) Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 106, 1455-1466
21. Popivanova, B. K., Kitamura, K., Wu, Y., Kondo, T., Kagaya, T., Kaneko, S., Oshima, M., Fujii, C., and Mukaida, N. (2008) Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J. Clin. Invest. 118, 560-570
22. Rogler, G., and Andus, T. (1998) Cytokines in inflammatory bowel disease. World J. Surg. 22, 382-389
23. Gonzalez-Juanatey, C., and Gonzalez-Gay, M. A. (2005) Rheumatoid arthritis and anti-TNF-alpha therapy. Atherosclerosis 181, 209
24. Osterman, M. T., and Lichtenstein, G. R. (2007) Current and future anti-TNF therapy for inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 10, 195-207
25. Allende, M. L., Sasaki, T., Kawai, H., Olivera, A., Mi, Y., van Echten-Deckert, G., Hajdu, R., Rosenbach, M., Keohane, C. A., Mandala, S., Spiegel, S., and Proia, R. L. (2004) Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J. Biol. Chem. 279, 52487-52492
26. Suzuki, R., Kohno, H., Sugie, S., Nakagama, H., and Tanaka, T. (2006) Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice. Carcinogenesis 27, 162-169
27. Bielawski, J., Szulc, Z. M., Hannun, Y. A., and Bielawska, A. (2006) Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods 39, 82-91
28. Olivera, A., Rosenthal, J., and Spiegel, S. (1996) Effect of acidic phospholipids on sphingosine kinase. J. Cell. Biochem. 60, 529-537
29. Muller, P. Y., Janovjak, H., Miserez, A. R., and Dobbie, Z. (2002) Processing of gene expression data generated by quantitative real-time RT-PCR. BioTechniques 32, 1372-1379
30. Singer, I. I., Kawka, D. W., Schloemann, S., Tessner, T., Riehl, T., and Stenson, W. F. (1998) Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 115, 297-306
31. Lin, C. I., Chen, C. N., Chen, J. H., and Lee, H. (2006) Lysophospholipids increase IL-8 and MCP-1 expressions in human umbilical cord vein endothelial cells through an IL-1-dependent mechanism. J. Cell. Biochem. 99, 1216-1232
32. Murch, S. H., Braegger, C. P., Walker-Smith, J. A., and MacDonald, T. T. (1993) Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut 34, 1705-1709
33. Olson, A. D., Ayass, M., and Chensue, S. (1993) Tumor necrosis factor and IL-1 beta expression in pediatric patients with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 16, 241-246
34. Zhi, L., Leung, B. P., and Melendez, A. J. (2006) Sphingosine kinase 1 regulates pro-inflammatory responses triggered by TNFalpha in primary human monocytes. J. Cell. Physiol. 208, 109-115
35. Johnson, K. R., Johnson, K. Y., Crellin, H. G., Ogretmen, B., Boylan, A. M., Harley, R. A., and Obeid, L. M. (2005) Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue. J. Histochem. Cytochem. 53, 1159-1166
36. Kaneider, N. C., Djanani, A., Fischer-Colbrie, R., and Wiedermann, C. J. (2002) Sphingosine kinase-dependent directional migration of leukocytes in response to phorbol ester. Biochem. Biophys. Res. Commun. 297, 806-810
37. Kawa, S., Kimura, S., Hakomori, S., and Igarashi, Y. (1997) Inhibition of chemotactic motility and trans-endothelial migration of human neutrophils by sphingosine 1-phosphate. FEBS Lett. 420, 196-200
38. Kohno, T., and Igarashi, Y. (2008) Attenuation of cell motility observed with high doses of sphingosine 1-phosphate or phosphorylated FTY720 involves RGS2 through its interactions with the receptor S1P. Genes Cells 13, 747-757
39. Vlasenko, L. P., and Melendez, A. J. (2005) A critical role for sphingosine kinase in anaphylatoxin-induced neutropenia, peritonitis, and cytokine production in vivo. J. Immunol. 174, 6456-6461
40. Zemann, B., Urtz, N., Reuschel, R., Mechtcheriakova, D., Bornancin, F., Badegruber, R., Baumruker, T., and Billich, A. (2007) Normal neutrophil functions in sphingosine kinase type 1 and 2 knockout mice. Immunol. Lett. 109, 56-63
41. Hendel, J., and Nielsen, O. H. (1997) Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease. Am. J. Gastroenterol. 92, 1170-1173
42. Tsubouchi, R., Hayashi, S., Aoi, Y., Nishio, H., Terashima, S., Kato, S., and Takeuchi, K. (2006) Healing impairment effect of cyclooxygenase inhibitors on dextran sulfate sodium-induced colitis in rats. Digestion 74, 91-100
43. Cuzzocrea, S., Mazzon, E., Serraino, I., Dugo, L., Centorrino, T., Ciccolo, A., Sautebin, L., and Caputi, A. P. (2001) Celecoxib, a selective cyclo-oxygenase-2 inhibitor reduces the severity of experimental colitis induced by dinitrobenzene sulfonic acid in rats. Eur. J. Pharmacol. 431, 91-102
44. Kohno, H., Suzuki, R., Sugie, S., and Tanaka, T. (2005) Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands. BMC Cancer 5, 46
45. Inoue, T., Hirata, I., and Murano, M. (2008) Effects of nimesulide, a cyclooxygenase-2 selective inhibitor, on colitis induced tumors. Inflammopharmacology 16, 36-39
46. Martin, A. R., Villegas, I., and Alarcon de la Lastra, C. (2005) The COX-2 inhibitor, rofecoxib, ameliorates dextran sulphate sodium induced colitis in mice. Inflamm. Res. 54, 145-151
47. Maines, L. W., Fitzpatrick, L. R., French, K. J., Zhuang, Y., Xia, Z., Keller, S. N., Upson, J. J., and Smith, C. D. (2008) Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase. Dig. Dis. Sci. 53, 997-1012
48. Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., and Cyster, J. G. (2004) Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427, 355-360
49. Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G. J., Card, D., Keohane, C., Rosenbach, M., Hale, J., Lynch, C. L., Rupprecht, K., Parsons, W., and Rosen, H. (2002) Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science (New York) 296, 346-349
50. Pappu, R., Schwab, S. R., Cornelissen, I., Pereira, J. P., Regard, J. B., Xu, Y., Camerer, E., Zheng, Y. W., Huang, Y., Cyster, J. G., and Coughlin, S. R. (2007) Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science (New York) 316, 295-298
51. Daniel, C., Sartory, N. A., Zahn, N., Schmidt, R., Geisslinger, G., Radeke, H. H., and Stein, J. M. (2007) FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions. Mol. Immunol. 44, 3305-3316
52. Daniel, C., Sartory, N., Zahn, N., Geisslinger, G., Radeke, H. H., and Stein, J. M. (2007) FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells. J. Immunol. 178, 2458-2468